Style | Citing Format |
---|---|
MLA | Shirvani G, et al.. "Synthesis of (2-Mercaptoacetyl)-L-[2-14C]Tryptophan As a Selective Metallo-Β-Lactamase Inhibitor Via [2-14C]Indole Based on Chiral Pool Strategy." Journal of Labelled Compounds and Radiopharmaceuticals, vol. 60, no. 2, 2017, pp. 130-134. |
APA | Shirvani G, Shockravi A, Amini M, Saemian N (2017). Synthesis of (2-Mercaptoacetyl)-L-[2-14C]Tryptophan As a Selective Metallo-Β-Lactamase Inhibitor Via [2-14C]Indole Based on Chiral Pool Strategy. Journal of Labelled Compounds and Radiopharmaceuticals, 60(2), 130-134. |
Chicago | Shirvani G, Shockravi A, Amini M, Saemian N. "Synthesis of (2-Mercaptoacetyl)-L-[2-14C]Tryptophan As a Selective Metallo-Β-Lactamase Inhibitor Via [2-14C]Indole Based on Chiral Pool Strategy." Journal of Labelled Compounds and Radiopharmaceuticals 60, no. 2 (2017): 130-134. |
Harvard | Shirvani G et al. (2017) 'Synthesis of (2-Mercaptoacetyl)-L-[2-14C]Tryptophan As a Selective Metallo-Β-Lactamase Inhibitor Via [2-14C]Indole Based on Chiral Pool Strategy', Journal of Labelled Compounds and Radiopharmaceuticals, 60(2), pp. 130-134. |
Vancouver | Shirvani G, Shockravi A, Amini M, Saemian N. Synthesis of (2-Mercaptoacetyl)-L-[2-14C]Tryptophan As a Selective Metallo-Β-Lactamase Inhibitor Via [2-14C]Indole Based on Chiral Pool Strategy. Journal of Labelled Compounds and Radiopharmaceuticals. 2017;60(2):130-134. |
BibTex | @article{ author = {Shirvani G and Shockravi A and Amini M and Saemian N}, title = {Synthesis of (2-Mercaptoacetyl)-L-[2-14C]Tryptophan As a Selective Metallo-Β-Lactamase Inhibitor Via [2-14C]Indole Based on Chiral Pool Strategy}, journal = {Journal of Labelled Compounds and Radiopharmaceuticals}, volume = {60}, number = {2}, pages = {130-134}, year = {2017} } |
RIS | TY - JOUR AU - Shirvani G AU - Shockravi A AU - Amini M AU - Saemian N TI - Synthesis of (2-Mercaptoacetyl)-L-[2-14C]Tryptophan As a Selective Metallo-Β-Lactamase Inhibitor Via [2-14C]Indole Based on Chiral Pool Strategy JO - Journal of Labelled Compounds and Radiopharmaceuticals VL - 60 IS - 2 SP - 130 EP - 134 PY - 2017 ER - |